Statistics for The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis
Total visits
views | |
---|---|
The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis | 194 |
Total visits per month
views | |
---|---|
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
nihms973526.pdf | 191 |
java.util.UUID:9c379f3a-0742-4cb9-aa1c-8a7aab9edffb | 35 |
java.util.UUID:aeb2edaf-5bf7-4f13-b370-6bbe886d7032 | 13 |
java.util.UUID:4fdb8a34-f311-4950-9555-a1a9a46d256c | 9 |
Top country views
views | |
---|---|
United States | 143 |
Germany | 7 |
United Kingdom | 5 |
Sweden | 5 |
Ukraine | 5 |
Canada | 2 |
China | 1 |
France | 1 |
Japan | 1 |
South Korea | 1 |
Malaysia | 1 |
Netherlands | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Wilmington | 45 |
Fairfield | 24 |
Houston | 11 |
Cambridge | 8 |
Falls Church | 8 |
White Plains | 7 |
Jacksonville | 6 |
Kiev | 5 |
Kiez | 5 |
San Francisco | 5 |
Stockholm | 4 |
Ann Arbor | 2 |
Baltimore | 2 |
Chicago | 2 |
Evanston | 2 |
Gunzenhausen | 2 |
Toronto | 2 |
Beijing | 1 |
Brooklyn | 1 |
City of Westminster | 1 |
Kista | 1 |
Lafayette | 1 |
Leiden | 1 |
Notre Dame | 1 |
Roubaix | 1 |
Scottsdale | 1 |
Seattle | 1 |
Seoul | 1 |
Seremban | 1 |
Trumbull | 1 |
Zheleznogorsk | 1 |